Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shoichiro Ohta

Showing results (1-10 of 106) with videos related to

Pageof 11
Sort By:
Allergy, Asthma & Immunology Research|September 2, 2016
Using Periostin as a Biomarker in the Treatment of AsthmaKenji Izuhara, Shoichiro Ohta, Junya Ono
Urology|December 11, 2003
Tissue factor expression and prognosis in patients with metastatic prostate cancerTakuya Akashi, Yuzo Furuya, Shoichiro Ohta, et al.
Rinsho Byori. the Japanese Journal of Clinical Pathology|May 22, 2007
[Clarification of the pathogenesis and development of clinical examination for allergic diseases]Kenji Izuhara, Sachiko Kanaji, Shoichiro Ohta, et al.
Biochemical and Biophysical Research Communications|September 24, 2004
Identification of a novel isoform of MD-2 that downregulates lipopolysaccharide signalingShoichiro Ohta, Uleng Bahrun, Mariko Tanaka, et al.
Advances in Experimental Medicine and Biology|May 1, 2019
Ability of Periostin as a New Biomarker of Idiopathic Pulmonary FibrosisMasaki Okamoto, Kenji Izuhara, Shoichiro Ohta, et al.
Pharmacology|November 11, 2020
Febuxostat Attenuates the Induction of Vascular Cell Adhesion Protein 1 by TNF-α in Human Umbilical Vein Endothelial CellsYasuhiro Suzuki, Mari Deguchi, Airi Furuya, et al.
Rinsho Byori. the Japanese Journal of Clinical Pathology|December 18, 2008
[Establishment of a diagnostic system for allergic diseases aiming at personalized medicine--establishment of a novel ELISA system for SCCA]Shoichiro Ohta, Yoshinori Azuma, Hiroshi Shiraishi, et al.
Anticancer Research|August 21, 2003
Clinical significance of expression of urokinase-type plasminogen activator in patients with prostate cancerShoichiro Ohta, Hideki Fuse, Yasuyoshi Fujiuchi, et al.
Medicinal Chemistry (Shariqah (United Arab Emirates))|August 5, 2008
Involvement of cysteine protease inhibitors in the defense mechanism against parasitesKenji Izuhara, Sachiko Kanaji, Kazuhiko Arima, et al.
Current Urology|June 12, 2014
Laparoscopic Varicocelectomy Carried Out with the LigaSure Device in 52 PatientsIsoji Sasagawa, Yuko Hirose, Kaori Matsuda, et al.
Pageof 11

Showing results (1-10 of 106) with videos related to

Sort By:
Pageof 11
Allergy, Asthma & Immunology Research|September 2, 2016
Using Periostin as a Biomarker in the Treatment of AsthmaKenji Izuhara, Shoichiro Ohta, Junya Ono
Urology|December 11, 2003
Tissue factor expression and prognosis in patients with metastatic prostate cancerTakuya Akashi, Yuzo Furuya, Shoichiro Ohta, et al.
Rinsho Byori. the Japanese Journal of Clinical Pathology|May 22, 2007
[Clarification of the pathogenesis and development of clinical examination for allergic diseases]Kenji Izuhara, Sachiko Kanaji, Shoichiro Ohta, et al.
Biochemical and Biophysical Research Communications|September 24, 2004
Identification of a novel isoform of MD-2 that downregulates lipopolysaccharide signalingShoichiro Ohta, Uleng Bahrun, Mariko Tanaka, et al.
Advances in Experimental Medicine and Biology|May 1, 2019
Ability of Periostin as a New Biomarker of Idiopathic Pulmonary FibrosisMasaki Okamoto, Kenji Izuhara, Shoichiro Ohta, et al.
Pharmacology|November 11, 2020
Febuxostat Attenuates the Induction of Vascular Cell Adhesion Protein 1 by TNF-α in Human Umbilical Vein Endothelial CellsYasuhiro Suzuki, Mari Deguchi, Airi Furuya, et al.
Rinsho Byori. the Japanese Journal of Clinical Pathology|December 18, 2008
[Establishment of a diagnostic system for allergic diseases aiming at personalized medicine--establishment of a novel ELISA system for SCCA]Shoichiro Ohta, Yoshinori Azuma, Hiroshi Shiraishi, et al.
Anticancer Research|August 21, 2003
Clinical significance of expression of urokinase-type plasminogen activator in patients with prostate cancerShoichiro Ohta, Hideki Fuse, Yasuyoshi Fujiuchi, et al.
Medicinal Chemistry (Shariqah (United Arab Emirates))|August 5, 2008
Involvement of cysteine protease inhibitors in the defense mechanism against parasitesKenji Izuhara, Sachiko Kanaji, Kazuhiko Arima, et al.
Current Urology|June 12, 2014
Laparoscopic Varicocelectomy Carried Out with the LigaSure Device in 52 PatientsIsoji Sasagawa, Yuko Hirose, Kaori Matsuda, et al.
Pageof 11